On the recordOctober 3, 2011
I think, again, our current judgment is that we think that more comprehensive drug utilization review is the best strategy right now.
Source
congress.govEditor's note · Context
Carper emphasizes the need for comprehensive drug utilization review.
Share
More from Tom Carper
Jul 25, 2024
We will do it again. Maybe the next time we will actually make it to Columbia.
Jun 18, 2024
Yes. The notification is meant to provide an additional mechanism for Congress to use in the oversight of the Commission's activities relating to nuclear exports. However, nothing in the ADVANCE Act changes the NRC's current…
Jun 18, 2024
Yes, I can. Let me be clear on this point--and I thank the Senator for pointing it out--the ADVANCE Act does not in any way alter the Nuclear Regulatory Commission's longstanding statutory responsibility to protect public health, safety…
Jun 18, 2024
The ADVANCE Act has no effect on the current authorities of the Commission, the Secretaries of Energy, State, or any other Federal Agency involved in the export of nuclear technology. The notification in section 103 exists in addition to…
Other voices in this conversation
